Is it time to conduct phase 3 clinical trials of sex hormones in MS - Commentary

Mult Scler. 2018 Oct;24(11):1417-1418. doi: 10.1177/1352458518786071. Epub 2018 Jul 30.

Authors

Anne-Laure Dubessy¹, Bruno Stankoff¹

Affiliation

¹ Institut du Cerveau et de la Moelle épinière (ICM), Sorbonne Universités, Hôpital de la Pitié Salpêtrière, Inserm UMR S 1127, CNRS UMR 7225, Paris, France/AP-HP, Hôpital de la Pitié Salpêtrière and Hôpital Saint Antoine, Paris, France.

PMID: 30058471
DOI: 10.1177/1352458518786071

No abstract available

MeSH terms

Clinical Trials, Phase III as Topic*
Female
Gonadal Steroid Hormones / therapeutic use*
Humans
Male
Multiple Sclerosis / drug therapy*

Substances

Gonadal Steroid Hormones